Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2020-10-08 History
Report ID 123744
Drug Identification Number 02423766
Brand name MIDAZOLAM INJECTION
Common or Proper name MIDAZOLAM
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MIDAZOLAM
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 1ML VIALS
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-09-25
Actual start date
Estimated end date
Actual end date 2020-10-07
Shortage status Resolved
Updated date 2020-10-08
Company comments Item has been discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-09-03 English Compare
v2 2020-09-03 English Compare
v3 2020-09-03 French Compare
v4 2020-09-26 English Compare
v5 2020-10-07 English Compare
v6 2020-10-07 French Compare
v7 2020-10-08 English Compare

Showing 1 to 7 of 7